Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Effect of Add-on Pentoxifylline Therapy on Proteinuria and eGFR in Membranous Glomerulonephritis: A 6-Month Randomized Placebo-Controlled Trial

  • At: 2012 FIP Congress in Amsterdam (the Netherlands)
  • Type: Poster
  • By: BADRI, Shirinsadat (Tehran University of Medical Sciences, Department of Clinical Pharmacy, Tehran, Iran)
  • Co-author(s): Dashti-Khavidaki, S. (Tehran University of Medical Sciences, Tehran, Iran)
    Ahmadi, F. (Tehran University of Medical Sciences, Tehran, Iran)
    Mahdavi-Mazdeh, M. (Tehran University of Medical Sciences, Tehran, Iran)
    Abbasi, M.R. (Tehran University of Medical Sciences, Tehran, Iran)
  • Abstract:


    Background:

    Membranous glomerulonephritis (MGN) may have proteinuria as the main complication and strong risk factor to reach end-stage renal disease. Current therapeutic regimens provide only partial renoprotection. Data derived from both animal and human studies provide a scientific basis for the use of pentoxifylline (PTF) as an

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses